semaglutide and other weight loss medications Zepbound vs GLP-1 vs Wegovy: What's the Difference Transition to Branded Weight Loss

Combining phentermine with Ozempic raises safety concerns due to overlapping mechanisms and cardiovascular effects

Schedule a consultation at The West Institute.

Gastroparesis is a chronic condition that affects the normal motility of the stomach

AP announces stylebook changes

To improve the health of Americans, in June 2021, the FDA approved semaglutide, a once-weekly injection, for chronic weight management in adults when used in combination with a healthy diet and exercise.

Semaglutide side effects typically emerge within the first week of treatment, peak around weeks two through four, and often improve substantially by week six